SCHEMBL8802159

SCHEMBL8802159

CCc1onc(-c2ccc(S(=O)(=O)C(C)[Si](C)(C)C)cc2)c1-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.64
PTGS1 P23219 6/20 0.64
MT-CO2 P00403 3/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
LMNA P02545 1/20 0.48
CA3 P07451 1/20 0.48
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48
CYP3A4 P08684 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CHRM1 P11229 1/20 0.48
ADRA2B P18089 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
SLC6A2 P23975 1/20 0.48
PDE4A P27815 1/20 0.48
ADORA1 P30542 1/20 0.48
CA5A P35218 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167912 0.84 PTGS2 (0.68) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL13524347 0.84 PTGS2 (0.73) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL4880685 0.83 PTGS2 (0.77) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL2279510 0.80 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8802163 0.79 PTGS2 (0.64) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL14340629 0.76 PTGS2 (0.78) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL4880635 0.75 PTGS2 (0.72) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL5482270 0.73 PTGS2 (0.63) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL4891953 0.73 PTGS2 (0.78) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6013917 0.73 PTGS2 (0.60) PTGS2PTGS1MT-CO2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed